Simulations Plus, Inc. is a provider in the biopharma sector, offering advanced software and consulting services that enhance drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. It operates through two segments: software and services. The Company’s business units include cheminformatics, physiologically based pharmacokinetics, clinical pharmacology and pharmacometrics, quantitative systems pharmacology, adaptive learning & insights and medical communications. The Company operates in biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry. It delivers simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development. Its cutting-edge technology is licensed and utilized by pharmaceutical, biotechnology, and regulatory agencies worldwide.
Símbolo de cotizaciónSLP
Nombre de la empresaSimulations Plus Inc
Fecha de salida a bolsaJun 18, 1997
Director ejecutivoO'Connor (Shawn M)
Número de empleados212
Tipo de seguridadOrdinary Share
Fin del año fiscalJun 18
Dirección800 Park Offices Drive, Suite 401
CiudadRESEARCH TRIANGLE PARK
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal27709
Teléfono16617237723
Sitio Webhttps://www.simulations-plus.com/
Símbolo de cotizaciónSLP
Fecha de salida a bolsaJun 18, 1997
Director ejecutivoO'Connor (Shawn M)